Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodixanol vs Iopamidol in Patients with Renal Impairment and Diabetes Undergoing CT
NCT00209417Phase 4Terminated
- Sponsor
- GE HealthCare
- Start
- Jun 2005
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised trial of iodixanol (2 arms), sponsored by GE HealthCare. Primary endpoint: Assessment of the Incidence Rate of Contrast Medium-Induced Nephropathy (CIN). Started Jun 2005; status: terminated.
02
Drugs
iodixanol
Beyond the preview
Go deeper on NCT00209417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209417.